Ahmedabad plane crash: Worries of whistleblowers over quality of Boeing 787 Dreamliner raised again
London: The crash of the Boeing 787 Dreamliner in Ahmedabad on Thursday has reopened the issue of the quality of the aircraft and the concerns in this regard that had been raised by whistleblowers earlier.
John Barnett, who had worked for 30 years for Boeing and had also been quality manager at the North Charleston plant, where the 787 Dreamliner is built, had alleged to the BBC in 2019 that workers under pressure used sub-standard parts on aircrafts to prevent delay in production. He had also stated that although the managers were alerted, they had taken no action in the matter.
After his superannuation in 2017, Barnett had also commenced legal action against Boeing. In the week prior to his sudden death in March 2024, from an apparently self-inflicted gunshot wound, Barnett had been giving evidence in a whistleblower lawsuit against the company. He had claimed that he had found serious shortcomings in the quality of the planes manufactured, including in the oxygen systems, which could mean one that in four breathing masks would not work in an emergency.
He had said that the pressure on production was causing hurry in the assembly process and compromise in safety. Although Boeing has denied the allegation, Barnett has further said that in some cases sub-standard parts were retrieved from scrap bins and fitted to planes being manufactured.
Another whistleblower, Sam Salehpour, who has worked with Boeing for more than a decade and is currently a Boeing engineer, had told NBC News in April 2024 that the company should “ground every 787 Dreamliner jet worldwide” since there were warnings that the flights are at risk of premature failure.
He added that the crew members who assembled the planes failed to fill tiny gaps properly while joining separately manufactured parts of the fuselage. His attorneys said that this shortened the lifespan of a plane and lead it to risk catastrophic failure.
Salehpour also said that he faced retaliation, including exclusion from meetings, for having throwing light on the shortcomings in the manufacture process and expressing concerns over them.
Boeing, however, has always denied the charges and has insisted that the flight 787 was safe for use.
The Federal Aviation Administration (FAA) is currently investigating Salehpour’s allegations. It also started a probe in May 2024 after Boeing admitted in April 2024 that it may not have completed required inspections to confirm adequate bonding and grounding where the wings join the fuselage on certain 787 Dreamliners. The FAA probe team is also investigating whether company employees falsified aircraft records.
The plane that crashed in Ahmedabad is learned to be an 11-year-old Boeing 787-8 Dreamliner. This is also the first major accident of a 787 plane.
Currently, Boeing has issued a statement that the authorities are in contact with Air India regarding Flight 171 and are ready to support them. They have also expressed grief over the loss of life and offered condolences to the families of the passengers and all others affected by the accident.
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
PM Modi lauds reduction in tuberculosis incidence in India
New Delhi (PTI): Prime Minister Narendra Modi on Thursday lauded the reduction in the incidence of tuberculosis in India since 2015, which was twice the global rate of decline and credited it to the expansion of treatment coverage.
India's TB incidence, which refers to new cases emerging each year, reduced by 21 per cent, from 237 per lakh population in 2015 to 187 per lakh population in 2024, according to the World Health Organisation's Global TB Report 2025.
The reduction is almost double the pace of the decline observed globally at 12 per cent, the Health Ministry said.
"India's fight against TB is achieving remarkable momentum. The latest WHO Global tuberculosis report 2025 highlights that India has recorded a commendable reduction in TB incidence since 2015 and it is nearly twice the global rate of decline," Modi said in a post on X.
The Prime Minister said the decline in incidence of TB in India was one of the sharpest drops seen anywhere in the world.
"Equally heartening is the expansion of treatment coverage, the fall in 'missing cases' and the sustained rise in treatment success. I compliment all those who have worked towards achieving this success. We remain committed to ensuring a healthy and fit India," Modi said.
